A House Energy and Commerce health subcommittee will discuss the Prescription Drug User Fee Act on Feb. 1 and proposed user fees for biosimilars Feb. 7. The subcommittee also scheduled a hearing Feb. 15 on reauthorization of the FDA's user-fee program for devices.
House subcommittee schedules February hearings on user fees
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Assistant Vice President - Dental Director||
|Vice President of Finance||
Urban Health Plan, Inc.